These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 3708774)

  • 41. Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: comparative study of disopyramide, flecainide, and E-4031.
    Inoue H; Yamashita T; Usui M; Nozaki A; Sugimoto T
    Cardiovasc Res; 1991 Mar; 25(3):223-9. PubMed ID: 1903082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
    Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
    Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans.
    Walfridsson H; Anfinsen OG; Berggren A; Frison L; Jensen S; Linhardt G; Nordkam AC; Sundqvist M; Carlsson L
    Europace; 2015 Mar; 17(3):473-82. PubMed ID: 25082948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrophysiologic effects of SD-3212, a new class I antiarrhythmic drug, on canine atrial flutter and atrial action-potential characteristics.
    Fujiki A; Tani M; Hayashi H; Mizumaki K; Inoue H; Uemura H; Nakaya H
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):471-5. PubMed ID: 9156356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new animal model of atrial flutter.
    Pagé PL; Plumb VJ; Okumura K; Waldo AL
    J Am Coll Cardiol; 1986 Oct; 8(4):872-9. PubMed ID: 3760359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Electrophysiologic effects of a new class III antiarrhythmic agent, E-4031, on atrial flutter, atrial refractoriness, and conduction delay in a canine sterile pericarditis model.
    Shimizu A; Kaibara M; Centurion OA; Kapuku G; Hirata T; Fukatani M; Yano K; Hashiba K
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):656-62. PubMed ID: 7681913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of sympathetic stimulation on use dependence of lidocaine, mexiletine, and quinidine in an intact canine model.
    Newman D; Herre JM; Chin M; Scheinman MM; Franz M; Katzung B
    Can J Physiol Pharmacol; 1992 Feb; 70(2):219-24. PubMed ID: 1325863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Slow abnormal conduction in the low right atrium: its anatomic basis and relevance to atrial reentry.
    Yamashita T; Oikawa N; Inoue H; Murakawa Y; Nakajima T; Usui M; Ajiki K; Ohkawa S; Sugimoto T
    Am Heart J; 1994 Feb; 127(2):353-9. PubMed ID: 8296703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of procainamide and dl-sotalol on the changes of atrial electrophysiology induced by high current stimulation.
    Yu WC; Chen SA; Tai CT; Wen ZC; Feng AN; Ding YA; Chang MS
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2064-9. PubMed ID: 9826857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The class III antiarrhythmic drugs dofetilide and sotalol prevent AF induction by atrial premature complexes at doses that fail to terminate AF.
    Derakhchan K; Villemaire C; Talajic M; Nattel S
    Cardiovasc Res; 2001 Apr; 50(1):75-84. PubMed ID: 11282080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation.
    Feld GK; Cha Y
    J Cardiovasc Pharmacol Ther; 1997 Jul; 2(3):195-203. PubMed ID: 10684458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atrial reentry around an anatomic barrier with a partially refractory excitable gap. A canine model of atrial flutter.
    Frame LH; Page RL; Hoffman BF
    Circ Res; 1986 Apr; 58(4):495-511. PubMed ID: 3698216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P; Newman D; Berman N; Hardy J; Mitchell J
    J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiplexing studies of effects of rapid atrial pacing on the area of slow conduction during atrial flutter in canine pericarditis model.
    Shimizu A; Nozaki A; Rudy Y; Waldo AL
    Circulation; 1991 Mar; 83(3):983-94. PubMed ID: 1999046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation mapping of reentry around an anatomical barrier in the canine atrium: observations during the action of the class III agent, d-sotalol.
    Boyden PA; Graziano JN
    J Cardiovasc Electrophysiol; 1993 Jun; 4(3):266-79. PubMed ID: 8269299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway.
    Schoels W; Yang H; Gough WB; el-Sherif N
    Circ Res; 1991 Apr; 68(4):1117-26. PubMed ID: 2009611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute intravenous conversion of canine atrial flutter: comparison of antiarrhythmic agents.
    Buchanan LV; Kabell G; Gibson JK
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):539-44. PubMed ID: 7596120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.
    Kopelman HA; Woosley RL; Lee JT; Roden DM; Echt DS
    Am J Cardiol; 1988 May; 61(13):1006-11. PubMed ID: 3284316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.